FI20011446A - Pharmaceutical brivudine containing composition taken once daily - Google Patents

Pharmaceutical brivudine containing composition taken once daily Download PDF

Info

Publication number
FI20011446A
FI20011446A FI20011446A FI20011446A FI20011446A FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A FI20011446 A FI 20011446A
Authority
FI
Finland
Prior art keywords
brivudine
pharmaceutical
containing composition
once daily
taken once
Prior art date
Application number
FI20011446A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20011446A0 (en
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Richerche S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Richerche S P A filed Critical Berlin Chemie Ag
Publication of FI20011446A0 publication Critical patent/FI20011446A0/en
Publication of FI20011446A publication Critical patent/FI20011446A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI20011446A 2001-01-03 2001-07-03 Pharmaceutical brivudine containing composition taken once daily FI20011446A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number Publication Date
FI20011446A0 FI20011446A0 (en) 2001-07-03
FI20011446A true FI20011446A (en) 2002-07-04

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011446A FI20011446A (en) 2001-01-03 2001-07-03 Pharmaceutical brivudine containing composition taken once daily

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Also Published As

Publication number Publication date
ITMI20010009A0 (en) 2001-01-03
FR2818907B1 (en) 2006-05-26
ES2192456A1 (en) 2003-10-01
PT102642A (en) 2002-07-31
PL348480A1 (en) 2002-07-15
CZ20012464A3 (en) 2002-08-14
DK177084B1 (en) 2011-07-11
GB2370771A (en) 2002-07-10
HRPK20010345B3 (en) 2005-02-28
AT6141U1 (en) 2003-05-26
DK200101019A (en) 2002-07-04
CH695662A5 (en) 2006-07-31
PT102642B (en) 2003-06-30
SE0102309L (en) 2002-07-04
IE20010413A1 (en) 2003-04-16
UA76402C2 (en) 2006-08-15
HUP0102816A2 (en) 2002-10-28
FI20011446A0 (en) 2001-07-03
GB0110682D0 (en) 2001-06-20
HRP20010345A2 (en) 2003-08-31
FR2818907A1 (en) 2002-07-05
SE0102309D0 (en) 2001-06-28
SK9572001A3 (en) 2003-03-04
GR20010100322A (en) 2002-10-08
HUP0102816A3 (en) 2005-01-28
ES2192456B1 (en) 2005-02-01
SK287043B6 (en) 2009-10-07
HU0102816D0 (en) 2001-09-28
GR1004012B (en) 2002-11-01
ITMI20010009A1 (en) 2002-07-03
BE1014522A5 (en) 2003-12-02
NL1018431C2 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
ATE407663T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AZITHROMYCIN HAVING REDUCED ADVERSE EFFECTS
FI20011478A0 (en) Pharmaceutical composition
FR13C0072I1 (en) NEW VACCINE COMPOSITION
NO20033556L (en) Pharmaceutical Formulations
ATE553775T1 (en) VACCINE COMPOSITION
DK1395242T3 (en) Liquid pharmaceutical composition
NO20033384L (en) Pharmaceutical Formulation
DE60206889D1 (en) PHARMACEUTICAL FORMULATION CONTAINING BICALUTAMIDE
NO20035627D0 (en) Pharmaceutical formulation
DE60211183D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIBLE
FI20022128A (en) Pharmaceutical composition
ATE350016T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
ATE439847T1 (en) RIBAVIRIN SYRUP FORMULATIONS
FI20011446A (en) Pharmaceutical brivudine containing composition taken once daily
DE10291905D2 (en) Pharmaceutical composition
ATE350029T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
NO20042074L (en) Macrolides containing pharmaceutical compositions
DE10107261B4 (en) Pharmaceutical composition
NO20041236L (en) Pharmaceutical Formulation
FI5468U1 (en) Pharmaceutical composition
ITMO20010022V0 (en) ENVELOPE FOR BOTTLE
SE0100847D0 (en) Novel pharmaceutical composition
SE0101171D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
FD Application lapsed